Treatment with this disaccharide induces antineoplastic impacts toward EAC, as demonstrated by a significant decrease in tumor volume, body weight, number of viable tumor cells and the BCL2 expression as the anti-apoptotic gene. Here, BCL2 is linked to neoplasm.